tag:blogger.com,1999:blog-28450497.post7852223318529788546..comments2008-02-05T23:22:06.074-05:00Adam J. Fein, Ph.D.http://www.blogger.com/profile/15774296048321605590afein@pembrokeconsulting.comBlogger2125tag:blogger.com,1999:blog-28450497.post-30216321055306801632008-02-05T22:38:00.000-05:002008-02-05T22:38:00.000-05:00Adam,<BR/>Pfizer invested $8M in Supplyscape and is represented on their advisory council. FDA recommended to China that pedigrees and unit serialization is the answer for them. FDA knew this back in 1987 as the answer. Wholesalers have been pushing RFID after they got caught arbitraging. Manufacturers can take the political heat and pay to improve their efficiencies under the banner of patient safety. Counterfeiters get off with light penalties while internet sales and importation continue to be the source.<BR/>Can't wait to my Mom's $4 prescription at Wal-Mart hits $5 to pay for controls not targeted at deterence and root causes.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-28450497.post-22310860744279132132008-02-05T18:41:00.000-05:002008-02-05T18:41:00.000-05:00In almost all of the states it is PhRMA and Pfizer that is pushing the pedigree legislation and compliance. Interestingly, the model legislation they crafted leaves manufacturers and Authorized Distributors of Record (the folks PhRMA indicates as being o.k) out of any pedigree requirement. According to the following article http://www.cbsnews.com/stories/2008/02/05/ap/health/main3794623.shtml we now find out that they are the problem not the solution. Adam, I would be less worried about counterfeit medications than the supposedly "real" ones sold by the manufacturers to U.S. consumers.Anonymousnoreply@blogger.com